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I.  General 
 
The following reagents were purchased and used as received: 9-BBN dimer (Aldrich), NiBr2• 
diglyme (Aldrich; somewhat hygroscopic), KOt-Bu (Acros or Strem), n-hexanol (Aldrich; 
anhydrous), and i-Pr2O (Aldrich; anhydrous).  Unless otherwise noted, reactions were 
conducted with stirring in oven-dried glassware under an inert atmosphere. 
 
 
II.  Preparation of Materials 
 
MeHN NHMe  
(1S,2S)-N1,N2-Dimethyl-1,2-di(naphthalen-1-yl)ethane-1,2-diamine (1).  The title compound 
was synthesized from 2,2'-((1R,2R)-1,2-diaminoethane-1,2-diyl)diphenol and 1-naphthaldehyde 
according to a procedure by Chin,1 methylated according to a procedure by Alper,2 and purified 
by flash chromatography (2:33:65 NEt3:EtOAc:hexanes) to provide the desired ligand. 
                                                
(1) Kim, H.; Nguyen, Y.; Yen, C. P.-H.; Chagal, L.; Lough, A. J.; Kim, B. M.; Chin, J. J. Am. 
Chem. Soc. 2008, 130, 12184–12191. 
(2) Kuznetsov, V. F.; Jefferson, G. R.; Yap, G. P. A.; Alper, H. Organometallics 2002, 21, 4241–
4248. 
 S–2 
The (R,R) enantiomer was synthesized by the same method, except starting with 2,2'-
((1S,2S)-1,2-diaminoethane-1,2-diyl)diphenol. 
1H NMR (400 MHz, CDCl3) δ 8.27–8.14 (m, 2H), 7.72–7.54 (m, 6H), 7.41–7.30 (m, 6H), 4.69 (s, 
2H), 2.23 (s, 6H), 2.08 (br s, 2H). 
13C NMR (100 MHz, CDCl3) δ 137.3, 133.9, 132.3, 128.8, 127.6, 125.5, 125.3, 125.2, 125.1, 123.3, 
35.1. 
FT-IR (KBr) 2945, 2790, 1943, 1596, 1507, 1394, 1162, 1136, 1104 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C24H24N2: 340.2, found: 340.1. 
[α]23D = +77° (c = 0.011, CHCl3). 
 
Synthesis of starting materials.  These procedures have not been optimized. 
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Representative procedure for the synthesis of tertiary amides from secondary amines: 
Triethylamine (4.2 mL, 30 mmol) and then the α-chloro acyl chloride (20 mmol) were added 
dropwise to a 0 °C solution of the secondary amine (20 mmol) in CH2Cl2 (150 mL) in a 500-mL 
round-bottom flask.  Then, the reaction was allowed to warm to room temperature and stirred 
for 2 h.  Next, an aqueous solution of HCl (1 M; 50 mL) was added.  The organic layer was 
separated, washed with water (50 mL) and brine (50 mL), dried over Na2SO4, filtered, and 
concentrated. 
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Representative procedure for the synthesis of tertiary amides from primary amines: The 
secondary amide was synthesized from the primary amine according to the preceding 
procedure.  The unpurified secondary amide (20 mmol) was dissolved in dry THF (100 mL) in a 
250-mL round-bottom flask, and the solution was cooled to 0 °C.  Sodium hydride (0.48 g, 20 
mmol) was added, and the mixture was stirred at 0 °C for 30 min.  Next, MeI (1.2 mL, 20 mmol) 
was added dropwise over 1 min.  Then, the reaction mixture was stirred at 0 °C for 2 h, after 
which the reaction was quenched by the addition of water (20 mL).  The solvent was removed 
by rotary evaporation, and Et2O (100 mL) and water (100 mL) were added to the residue.  The 
organic layer was separated, washed with water (50 mL) and brine (50 mL), dried over Na2SO4, 
and concentrated. 
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Representative procedure for the reduction of amides to arylamines: Borane–THF (1.0 M; 
1.0 equiv) was added dropwise to a solution of the amide in dry THF (100 mL) in a 3-neck, 300-
mL round-bottom flask equipped with a stir bar and a reflux condenser.  After the addition was 
complete, the solution was heated at reflux for 18 h.  Next, it was allowed to cool to room 
temperature, and then the reaction was quenched by the addition of an aqueous solution of 
NaOH (1 M; 10 mL).  The THF was removed by rotary evaporation, and the resulting mixture 
was diluted with Et2O (100 mL).  The organic layer was separated, washed with water (100 mL) 
and brine (100 mL), dried over Na2SO4, filtered, and concentrated. 
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N-(2-Chloropropyl)-N-methylaniline.  Synthesized from N-methylaniline (3.5 mL, 32.3 
mmol) and 2-chloropropanoyl chloride (3.1 mL, 31.9 mmol).  Purified by chromatography 
(0%→50% Et2O/hexanes): 4.66 g (78% over 2 steps).  Clear oil. 
1H NMR (400 MHz, CDCl3) δ 7.28–7.23 (m, 2H), 6.76–6.67 (m, 3H), 4.28 (sextet, 1H, J = 7.2 
Hz), 3.68–3.61 (dd, 1H, J = 6.5, 15.2 Hz), 3.52–3.45 (dd, 1H, J = 7.3, 15.2 Hz), 3.04 (s, 3H), 1.53 (d, 
3H, J = 6.8 Hz). 
13C NMR (100 MHz, CDCl3) δ 148.7, 129.5, 116.9, 112.0, 61.2, 55.3, 40.0, 23.2. 
FT-IR (neat) 2976, 1601, 1509, 1353, 748, 692 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C10H14ClN: 183.1, found: 183.1. 
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N-(2-Chloro-3-methylbutyl)-N-methylaniline.  Synthesized from N-methylaniline (3.10 g, 
20.0 mmol) and 2-chloro-3-methylbutanoyl chloride (2.16 mL, 20.0 mmol).  Purified by 
chromatography (0%→50% Et2O/hexanes): 1.36 g (32% over 2 steps).  Yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.28–7.21 (m, 2H), 6.75–6.66 (m, 3H), 4.21–4.15 (m, 1H), 3.68 
(dd, 1H, J = 6.0, 15.4 Hz), 3.55 (dd, 1H, J = 7.6, 15.4 Hz), 3.03 (s, 3H), 2.09–2.00 (m, 1H), 1.08–1.02 
(m, 6H). 
13C NMR (100 MHz, CDCl3) δ 148.8, 129.5, 116.8, 112.1, 67.1, 57.9, 40.1, 31.7, 20.8, 16.4. 
FT-IR (neat) 2968, 2914, 1600, 1507, 1362, 1210, 747, 692 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C12H18ClN: 211.1, found: 211.1. 
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N-(2-Chloropropyl)-N-isopropylaniline.  Synthesized from N-isopropylaniline (4.50 mL, 
31.1 mmol) and 2-chloropropionyl chloride (3.10 mL, 31.1 mmol).  Purified by chromatography 
(0%→50% Et2O/hexanes): 1.74 g (27% over 2 steps).  Light-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.27–7.23 (m, 2H), 6.88–6.86 (m, 2H), 6.82–6.78 (m, 1H), 4.17–
4.01 (m, 1H), 3.99 (septet, 1H, J = 6.7 Hz), 3.50–3.45 (dd, 1H, J = 5.2, 14.8 Hz), 3.26–3.20 (dd, 1H, J 
= 8.6, 14.6 Hz), 1.50 (d, 3H, J = 6.8 Hz), 1.20 (d, 3H, J = 6.8 Hz), 1.13 (d, 3H, J = 6.8 Hz). 
13C NMR (100 MHz, CDCl3) δ 149.0, 129.4, 118.8, 116.8, 55.2, 52.4, 52.1, 23.2, 20.9, 20.0. 
FT-IR (neat) 2974, 1599, 1497, 1378, 1293, 1224, 1185, 1121, 1048, 1013, 910, 752, 696 cm–1. 
MS (EI) m/z (M+) calcd for C12H18ClN: 211, found: 211. 
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N-(2-Chloropropyl)-N-methylbiphenyl-4-amine.  Synthesized from 4-biphenylamine (3.38 
g, 20.0 mmol) and 2-chloropropanoyl chloride (1.97 mL, 20.0 mmol).  Purified by 
chromatography (5%→100% Et2O/hexanes): 2.08 g (40% over 3 steps).  White solid. 
mp 157 °C (dec.). 
1H NMR (400 MHz, CDCl3) δ 7.56–7.46 (m, 4H), 7.42–7.35 (m, 2H), 7.29–7.23 (m, 1H), 6.79–
6.73 (m, 2H), 4.32 (sextet, 1H, J = 6.7 Hz), 3.68 (dd, 1H, J = 6.5, 15.2 Hz), 3.54 (dd, 1H, J = 7.3, 15.2 
Hz), 3.09 (s, 3H), 1.57 (d, 3H, J = 6.6 Hz). 
13C NMR (100 MHz, CDCl3) δ 149.0, 141.7, 129.2, 128.4, 127.8, 126.2, 126.0, 112.1, 60.0, 55.0, 
39.8, 23.2. 
FT-IR (neat) 2924, 2845, 1612, 1505, 1456, 1201, 816, 761, 697 cm–1. 
MS (EI) m/z (M+) calcd for C16H18ClN: 259.1, found: 259.1. 
 
 
N
Me
ClMe
MeO
 
N-(2-Chloropropyl)-4-methoxy-N-methylaniline.  Synthesized from 4-methoxy-N-
methylaniline (2.17 g, 15.8 mmol) and 2-chloropropanoyl chloride (1.5 mL, 15.5 mmol).  Purified 
by chromatography (5%→100% Et2O/hexanes): 2.89 g (86% over 2 steps).  Yellow oil. 
1H NMR (400 MHz, CDCl3) δ 6.87–6.82 (m, 2H), 6.71–6.65 (m, 2H), 4.24 (sextet, 1H, J = 6.6 
Hz), 3.77 (s, 3H), 3.54 (dd, 1H, J = 6.4, 15.0 Hz), 3.37 (dd, 1H, J = 7.3 Hz, 15.0 Hz), 2.97 (s, 3H), 
1.52 (d, 3H, J = 6.6 Hz). 
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13C NMR (100 MHz, CDCl3) δ 152.0, 143.7, 115.1, 114.0, 62.3, 56.0, 55.4, 40.3, 23.2. 
FT-IR (neat) 2928, 1513, 1246, 1040, 814 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C11H16ClNO: 213.1, found: 213.1. 
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N-(2-Chlorohexyl)-N,3-dimethylaniline.  Synthesized from N-methyl-m-toluidine (2.00 g, 
16.5 mmol) and 2-chlorohexanoyl chloride (2.47 mL, 16.5 mmol).  Purified by chromatography 
(5%→100% Et2O/hexanes): 2.31 g (58% over 2 steps).  Yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.16–7.10 (m, 1H), 6.65–6.46 (m, 3H), 4.20–4.11 (m, 1H), 3.63–
3.51 (m, 2H), 3.02 (s, 3H), 2.32 (s, 3H), 1.89–1.78 (m, 1H), 1.72–1.55 (m, 2H), 1.47–1.25 (m, 3H), 
0.91 (t, 3H, J = 7.2 Hz). 
13C NMR (100 MHz, CDCl3) δ 150.1, 138.8, 129.1, 112.9, 110.4, 109.4, 59.2, 59.0, 39.7, 36.8, 28.9, 
23.5, 22.2, 14.2. 
FT-IR (neat) 2929, 2860, 1602, 1499, 1065, 764, 693, 668 cm–1. 
MS (EI) m/z (M+) calcd for C14H22ClN: 239.1, found: 239.1. 
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N-(2-Chlorohexyl)-3-methoxy-N-methylaniline.  Synthesized from 3-methoxyaniline (1.37 
g, 10.0 mmol) and 2-chlorohexanoyl chloride (1.69 g, 10.0 mmol).  Purified by chromatography 
(5%→100% Et2O/hexanes): 1.63 g (62% over 3 steps).  Yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.13 (t, 1H, J = 8.2 Hz), 6.28 (d, 2H, J = 8.0 Hz), 6.20 (t, 1H, J = 
2.2 Hz), 4.17–4.11 (m, 1H), 3.78 (s, 3H), 3.55 (d, 2H, J = 6.8 Hz), 3.01 (s, 3H), 1.85–1.76 (m, 1H), 
1.66–1.54 (m, 2H), 1.43–1.25 (m, 3H), 0.89 (t, 3H, J = 7.2 Hz). 
13C NMR (100 MHz, CDCl3) δ 161.0, 150.2, 130.2, 105.2, 101.5, 98.8, 60.9, 60.2, 55.3, 40.2, 35.9, 
28.8, 22.5, 14.2. 
FT-IR (neat) 2956, 2931, 2872, 1612, 1577, 1500, 1456, 1247, 1169, 1056, 824, 750, 687 cm–1. 
MS (EI) m/z (M+) calcd for C14H22ClNO: 255.1, found: 255.1. 
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N-(2-Chlorohexyl)-3-fluoro-N-methylaniline.  Synthesized from 3-fluoro-N-methylaniline 
(1.13 mL, 10.0 mmol) and 2-chlorohexanoyl chloride (1.69 g, 10.0 mmol).  Purified by 
chromatography (5%→50% Et2O/hexanes): 1.78 g (74% over 2 steps).  Yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.21–7.10 (m, 1H), 6.45–6.38 (m, 2H), 6.38–6.31 (m, 1H), 4.18–
4.10 (m, 1H), 3.57 (d, 2H, J = 6.8 Hz), 3.03 (s, 3H), 1.85–1.77 (m, 1H), 1.70–1.61 (m, 1H), 1.64–1.21 
(m, 4H), 0.91 (t, 3H, J = 7.1 Hz). 
13C NMR (100 MHz, CDCl3) δ 164.4 (d, J = 243 Hz), 150.4, 130.4 (d, J = 10 Hz), 107.6 (d, J = 22 
Hz), 99.1 (d, J = 26 Hz), 60.7, 60.0, 40.2, 35.8, 28.7, 22.5, 14.1. 
FT-IR (neat) 2988, 2931, 2886, 1621, 1577, 1502, 1362, 1235, 1162, 1009, 822, 754, 682 cm–1. 
MS (EI) m/z (M+) calcd for C13H19ClFN: 243.1, found: 243.1. 
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N-(2-Chloro-3-cyclohexylpropyl)-2-fluoro-N-methylaniline.  Synthesized from 2-
fluoroaniline (1.44 mL, 15.0 mmol) and 2-chloro-3-cyclohexylpropionyl chloride (3.14 g, 15.0 
mmol).  Purified by chromatography (5%→50% Et2O/hexanes): 1.80 g (42% over 3 steps).  
Yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.07–6.80 (m, 4H), 4.26–4.17 (m, 1H), 3.55–3.47 (m, 1H), 3.43–
3.35 (m, 1H), 2.96 (s, 3H), 1.79–1.47 (m, 7H), 1.33–1.05 (m, 3H), 1.00–0.73 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ 154.8 (d, J = 304.8 Hz), 139.2 (d, J = 10.3 Hz), 124.6 (d, J = 4.2 
Hz), 121.0 (d, J = 9.8 Hz), 119.2 (d, J = 4.5 Hz), 116.5 (d, J = 26.5 Hz), 62.4 (d, J = 7.3 Hz), 59.2 (d, J 
= 2.3 Hz), 43.8, 41.3, 34.9, 34.2, 32.1, 26.9, 26.5, 26.2. 
FT-IR (neat) 2923, 2852, 1614, 1505, 1448, 1230, 746 cm–1. 
MS (EI) m/z (M+) calcd for C16H23ClFN: 283.2, found: 283.1. 
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N-(2-Chloropropyl)-N-methylnaphthalen-2-amine.  Synthesized from 2-naphthylamine 
(2.00 g, 14.0 mmol) and 2-chloropropionyl chloride (1.38 mL, 14.0 mmol).  Purified by 
chromatography (0%→100% Et2O/hexanes): 1.82 g (55% over 3 steps).  White solid. 
mp 153 °C (dec.). 
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1H NMR (400 MHz, CDCl3) δ 7.73–7.62 (m, 3H), 7.40–7.34 (m, 1H), 7.25–7.18 (m, 1H), 7.13–
7.09 (m, 1H), 6.90–6.87 (m, 1H), 4.33 (sextet, 1H, J = 6.8 Hz), 3.76 (dd, 1H, J = 6.6, 15.2 Hz), 3.61 
(dd, 1H, J = 7.3, 15.2 Hz), 3.15 (s, 3H), 1.55 (d, 3H, J = 6.6 Hz). 
13C NMR (100 MHz, CDCl3) δ 147.8, 135.4, 128.8, 127.6, 126.5, 126.3, 126.2, 121.8, 116.1, 105.5, 
59.9, 55.2, 39.8, 23.8. 
FT-IR (neat) 2924, 2855, 1629, 1512, 824, 743 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C14H16ClN: 233.1, found: 233.1. 
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1-(2-Chlorohexyl)indoline.  Synthesized from indoline (1.12 mL, 10.0 mmol) and 2-
chlorohexanoyl chloride (1.69 g, 10.0 mmol).  Purified by chromatography (0%→50% 
Et2O/hexanes): 1.09 g (46% over 2 steps).  Clear oil. 
1H NMR (400 MHz, CDCl3) δ 7.11–7.04 (m, 2H), 6.70–6.64 (m, 1H), 6.48–6.44 (m, 1H), 4.13–
4.04 (m, 1H), 3.52–3.45 (m, 2H), 3.35 (dd, 1H, J = 6.6, 14.3 Hz), 3.29 (dd, 1H, J = 6.6, 14.3 Hz), 
3.05–3.00 (m, 2H), 1.99–1.88 (m, 1H), 1.77–1.55 (m, 2H), 1.50–1.22 (m, 3H), 0.93 (t, 3H, J = 7.2 Hz). 
13C NMR (100 MHz, CDCl3) δ 152.4, 129.5, 127.5, 124.7, 117.9, 106.5, 61.6, 57.6, 54.7, 35.9, 28.9, 
28.8, 22.5, 14.2. 
FT-IR (neat) 2956, 2930, 2859, 1607, 1489, 1267, 743 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C14H20ClN: 237.1, found: 237.1. 
 
 
III.  Stereoconvergent Suzuki Cross-Coupling Reactions 
 
General procedure (conducted in a glovebox; however, see the note below).  The 
trialkylborane was prepared by adding 9-BBN dimer (440 mg, 1.80 mmol), i-Pr2O (1.0 mL), and 
the alkene (3.60 mmol) in turn to a 4-mL vial.  The vial was capped and removed from the 
glovebox.  The reaction mixture was stirred at 60 °C for 1 h, and then it was allowed to cool to 
r.t.  The vial was taken back into the glovebox, and the reaction mixture was diluted with i-Pr2O 
to furnish a 1.5 M solution.  Next, a portion of this solution (0.9 mL, 1.35 mmol) was added to a 
solution of KOt-Bu (101 mg, 0.900 mmol) in n-hexanol (188 µL, 1.50 mmol) in a 4-mL vial.  The 
resulting mixture was stirred at r.t. for 30 min. 
A solution of NiBr2•diglyme (26.7 mg, 0.075 mmol) and (1R,2R)-N1,N2-dimethyl-1,2-
di(naphthalen-1-yl)ethane-1,2-diamine (30.8 mg, 0.090 mmol) in i-Pr2O (5.5 mL) in a 20-mL vial 
was stirred at r.t. for 30 min.  Next, the electrophile (0.75 mmol) was added, along with an i-
Pr2O rinsing (0.5 mL), and then the solution of the activated trialkylborane was added dropwise 
over 2 min.  The reaction mixture was stirred at r.t. for 40 h, and then it was filtered through 
silica gel, eluting with Et2O (20 mL).  The solvent was removed by rotary evaporation, and the 
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residue was diluted with hexanes (10 mL).  The resulting solution was filtered through an 
acrodisc and then concentrated by rotary evaporation. 
A second run was performed with the (1S,2S) enantiomer of ligand 1. 
Note: For the sake of convenience, the stereoconvergent Suzuki cross-couplings described in 
Table 1 were conducted in a glovebox.  However, this method does not require the use of a 
glovebox.  When carried out without a glovebox, the coupling illustrated in entry 1 of Table 1 
proceeded in 88% ee and 82% yield. 
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(S)-N-Methyl-N-(2-methyloctyl)aniline (Table 1, entry 1).  N-(2-Chloropropyl)-N-
methylaniline (138 mg, 0.75 mmol) and a solution of the reagent prepared by hydroboration of 
1-hexene with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 mL, 1.35 mmol) were used.  The 
product was purified by flash chromatography on reverse-phase silica gel (10% 
acetonitrile/water→acetonitrile).  Clear oil.  First run: 146 mg (83%, 88% ee).  Second run (6 
mmol scale): 1.20 g (86%, 88% ee). 
The ee was determined by HPLC on an OJ-H column (hexanes, 1.0 mL/min) with tr = 9.0 
min (minor), 9.7 min (major). 
1H NMR (400 MHz, CDCl3) δ 7.25–7.19 (m, 2H), 6.70–6.63 (m, 3H), 3.21 (dd, 1H, J = 6.6, 14.5 
Hz), 3.02 (dd, 1H, J = 8.1, 14.5 Hz), 2.95 (s, 3H), 1.98–1.82 (m, 1H), 1.44–1.04 (m, 10H), 0.92–0.83 
(m, 6H). 
13C NMR (100 MHz, CDCl3) δ 149.9, 129.3, 115.7, 112.0, 60.1, 39.7, 35.0, 32.5, 32.1, 29.9, 27.3, 
22.9, 18.0, 14.3. 
FT-IR (neat) 2956, 2926, 2856, 1729, 1600, 1507, 1465, 992, 746, 691 cm–1. 
MS (EI) m/z (M+) calcd for C16H27N: 233.2, found: 233.2. 
[α]23D = +7.3° (c 0.0075, CHCl3). 
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N-(2-Isopropyl-5-(2-methoxyphenyl)pentyl)-N-methylaniline (Table 1, entry 2).  N-(2-
Chloro-3-methylbutyl)-N-methylaniline (155 mg, 0.73 mmol) and a solution of the reagent 
prepared by hydroboration of 2-allylanisole with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 
mL, 1.32 mmol) were used with NiBr2•diglyme (51.6 mg, 0.146 mmol) and (1R,1R)-N1,N2-
dimethyl-1,2-di(naphthalen-1-yl)ethane-1,2-diamine (59.8 mg, 0.176 mmol).  The product was 
purified by flash chromatography on reverse-phase silica gel (10% 
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acetonitrile/water→acetonitrile).  Yellow oil.  First run: 126 mg (53%, 95% ee).  Second run: 123 
mg (52%, 98% ee). 
The ee was determined by SFC on an OJ-H column (5% MeOH/CO2(l), 3.0 mL/min, 100 bar) 
with tr = 10.6 min (minor), 12.7 min (major). 
1H NMR (400 MHz, CDCl3) δ 7.27–7.12 (m, 4H), 6.92–6.85 (m, 2H), 6.73–6.68 (m, 3H), 3.83 (s, 
3H), 3.28 (dd, 1H, J = 7.2, 14.8 Hz), 3.20 (dd, 1H, J = 7.4, 14.6 Hz), 2.93 (s, 3H), 2.64–2.60 (m, 2H), 
1.89–1.76 (m, 2H), 1.70–1.61 (m, 2H), 1.47–1.39 (m, 1H), 1.35–1.25 (m, 1H), 0.95 (d, 3H, J = 6.8 
Hz), 0.93 (d, 3H, J = 6.8 Hz). 
13C NMR (100 MHz, CDCl3) δ 157.4, 149.9, 130.1, 129.7, 129.0, 126.8, 120.3, 115.5, 111.9, 110.1, 
55.2, 54.5, 41.9, 39.3, 30.7, 28.3, 27.9, 27.6, 19.5, 18.3. 
FT-IR (neat) 2955, 2361, 1600, 1507, 1465, 1359, 1242, 1128, 1051, 1033, 992, 929, 858, 749, 692 
cm–1. 
MS (EI) m/z (M+) calcd for C22H31NO: 325, found: 325. 
[α]24D = +8.6° (c 0.0095, CH2Cl2). 
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(S)-N-Isopropyl-N-(5-(2-methoxyphenyl)-2-methylpentyl)aniline (Table 1, entry 3).  N-(2-
Chloropropyl)-N-isopropylaniline (158 mg, 0.75 mmol) and a solution of the reagent prepared 
by hydroboration of 2-allylanisole with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 mL, 1.35 
mmol) were used.  The product was purified by flash chromatography on reverse-phase silica 
gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  First run: 167 mg (69%, 81% ee).  Second 
run: 182 mg (75%, 82% ee). 
The ee was determined by HPLC on an OD-H column (100% hexanes, 1.0 mL/min) with tr = 
20.6 min (major), 23.8 min (minor). 
1H NMR (400 MHz, CDCl3) δ 7.21–7.08 (m, 4H), 6.88–6.80 (m, 4H), 6.70 (t, 1H, J = 7.2 Hz), 
3.97 (septet, 1H, J = 6.8 Hz), 3.79 (s, 3H), 2.96 (dd, 1H, J = 6.2, 14.2 Hz), 2.75 (dd, 1H, J = 8.0, 14.4 
Hz), 2.65–2.63 (m, 2H), 1.81–1.79 (m, 2H), 1.66–1.51 (m, 2H), 1.21–1.19 (m, 1H), 1.13 (d, 3H, J = 
6.4 Hz), 1.09 (d, 3H, J = 6.8 Hz), 0.85 (d, 3H, J = 6.8 Hz). 
13C NMR (100 MHz, CDCl3) δ 157.4, 149.8, 131.1, 129.8, 128.7, 126.8, 120.2, 117.1, 116.3, 110.1, 
55.1, 51.9, 49.9, 34.9, 30.7, 30.5, 27.3, 20.3, 19.8, 17.9. 
FT-IR (neat) 2930, 1599, 1496, 1464, 1362, 1290, 1243, 1195, 1126, 1051, 1032, 752, 696 cm–1. 
MS (EI) m/z (M+) calcd for C22H31NO: 325 found: 325. 
 [α]24D = –33° (c 0.011, CH2Cl2; from (1S,2S)-1). 
 
 
 S–10 
N
Me
Me
Ph
 
(S)-N-(5-Cyclohexyl-2-methylpentyl)-N-methylbiphenyl-4-amine (Table 1, entry 4).  N-(2-
Chloropropyl)-N-methylbiphenyl-4-amine (195 mg, 0.75 mmol) and a solution of the reagent 
prepared by hydroboration of allylcyclohexane with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 
mL, 1.35 mmol) were used.  The product was purified by flash chromatography on reverse-
phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  First run: 184 mg (70%, 85% 
ee).  Second run: 172 mg (66%, 85% ee). 
The ee was determined by HPLC on an OJ-H column (1% isopropanol/hexanes, 1.0 
mL/min) with tr = 19.3 min (minor), 23.8 min (major). 
1H NMR (400 MHz, CDCl3) δ 7.58–7.54 (m, 2H), 7.52–7.47 (m, 2H), 7.42–7.36 (m, 2H), 7.27–
7.22 (m, 1H), 6.77–6.72 (m, 2H), 3.27 (dd, 1H, J = 6.6, 14.6 Hz), 3.07 (dd, 1H, J = 8.1, 14.6 Hz), 3.01 
(s, 3H), 2.00–1.90 (m, 1H), 1.74–1.53 (m, 4H), 1.47–1.06 (m, 10H), 0.92 (d, 3H, J = 6.8 Hz), 0.94–
0.80 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ 149.2, 141.5, 128.8, 128.4, 127.9, 126.4, 126.0, 112.1, 60.0, 39.8, 
38.1, 37.9, 35.2, 33.8, 33.6, 32.5, 31.1, 27.0, 26.7, 24.5, 18.0. 
FT-IR (neat) 2922, 2850, 1612, 1525, 1490, 1200, 816, 761, 696 cm–1. 
MS (EI) m/z (M+) calcd for C25H35N: 349.3, found: 349.3. 
[α]23D = +7.6° (c 0.0060, CHCl3). 
 
 
N
Me
n-HexMe
MeO
 
(S)-4-Methoxy-N-methyl-N-(2-methyloctyl)aniline (Table 1, entry 5).  N-(2-Chloropropyl)-
4-methoxy-N-methylaniline (160 mg, 0.75 mmol) and a solution of the reagent prepared by 
hydroboration of 1-hexene with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 mL, 1.35 mmol) 
were used.  The product was purified by flash chromatography on reverse-phase silica gel (10% 
acetonitrile/water→acetonitrile).  Yellow oil.  First run: 152 mg (77%, 88% ee).  Second run: 148 
mg (75%, 86% ee). 
The ee was determined by HPLC on an OJ-H column (1% isopropanol/hexanes, 1.0 
mL/min) with tr = 7.4 min (major), 8.3 min (minor). 
1H NMR (400 MHz, CDCl3) δ 6.86–6.80 (m, 2H), 6.69–6.62 (m, 2H), 3.76 (s, 3H), 3.11 (dd, 1H, J 
= 6.6, 14.3 Hz), 2.93 (dd, 1H, J = 8.1, 14.3 Hz), 2.87 (s, 3H), 1.91–1.78 (m, 1H), 1.44–1.00 (m, 10H), 
0.91–0.84 (m, 6H). 
13C NMR (100 MHz, CDCl3) δ 151.3, 145.3, 114.9, 113.9, 61.3, 56.1, 40.1, 35.0, 32.5, 32.1, 29.9, 
27.3, 22.9, 18.1, 14.4. 
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FT-IR (neat) 2955, 2926, 2855, 1513, 1464, 1244, 1181, 1043, 811 cm–1. 
MS (EI) m/z (M+) calcd for C17H29NO: 263.2, found: 263.2. 
[α]23D = +4.4° (c 0.0051, CHCl3). 
 
 
N
Me
Me
MeO
Me
Me  
(S)-N-(2,6-Dimethylheptyl)-4-methoxy-N-methylaniline (Table 1, entry 6).  N-(2-
Chloropropyl)-4-methoxy-N-methylaniline (160 mg, 0.75 mmol) and a solution of the reagent 
prepared by hydroboration of 4-methylpent-1-ene with 9-BBN dimer (1.5 M solution in i-Pr2O; 
0.90 mL, 1.35 mmol) were used.  The product was purified by flash chromatography on reverse-
phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  First run: 150 mg (76%, 84% 
ee).  Second run: 155 mg (79%, 85% ee). 
The ee was determined by SFC on an OD-H column (2.5% MeOH/CO2(l), 3.0 mL/min, 100 
bar) with tr = 5.7 min (minor), 6.0 min (major). 
1H NMR (400 MHz, CDCl3) δ 6.86–6.80 (m, 2H), 6.69–6.63 (m, 2H), 3.76 (s, 3H), 3.10 (dd, 1H, J 
= 6.8, 14.4 Hz), 2.93 (dd, 1H, J = 8.0, 14.4 Hz), 2.87 (s, 3H), 1.90–1.80 (m, 1H), 1.58–1.46 (m, 1H), 
1.42–1.31 (m, 2H), 1.31–1.19 (m, 1H), 1.18–1.01 (m, 3H), 0.91–0.84 (m, 9H). 
13C NMR (100 MHz, CDCl3) δ 151.3, 145.3, 115.0, 113.9, 61.3, 56.1, 40.1, 39.6, 35.2, 32.3, 28.2, 
25.0, 23.0, 22.8, 18.1. 
FT-IR (neat) 2954, 2928, 2868, 1514, 1244, 1181, 1043, 811, 700 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C17H29NO: 263.2, found: 263.1. 
[α]23D = +4.3° (c 0.0080, CHCl3). 
 
 
N
n-Bu
(CH2)3OTBSMe
Me
 
(S)-N-(2-(3-(tert-Butyldimethylsilyloxy)propyl)hexyl)-N,3-dimethylaniline (Table 1, entry 
7).  N-(2-Chlorohexyl)-N,3-dimethylaniline (180 mg, 0.75 mmol) and a solution of the reagent 
prepared by hydroboration of allyloxy(tert-butyl)dimethylsilane with 9-BBN dimer (1.5 M 
solution in i-Pr2O; 0.90 mL, 1.35 mmol) were used.  The product was purified by flash 
chromatography on reverse-phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  
First run: 166 mg (59%, 90% ee).  Second run: 191 mg (67%, 92% ee). 
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The ee was determined by HPLC of the corresponding desilylated alcohol3 on an OJ-H 
column (1% isopropanol/hexanes, 1.0 mL/min) with tr = 21.5 min (major), 23.0 min (minor). 
1H NMR (400 MHz, CDCl3) δ 7.11–7.07 (m, 1H), 6.48–6.47 (m, 3H), 3.56 (t, 2H, J = 6.6 Hz), 
3.15–3.12 (m, 2H), 2.90 (s, 3H), 2.29 (s, 3H), 1.80 (br s, 1H), 1.54–1.52 (m, 2H), 1.28–1.27 (m, 8H), 
0.87 (s, 12 H), 0.02 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 149.9, 138.6, 128.9, 116.6, 112.6, 109.2, 63.6, 57.6, 39.5, 36.4, 31.3, 
29.8, 28.7, 27.6, 26.0, 23.2, 22.0, 18.3, 14.1, –5.3. 
FT-IR (neat) 2928, 1602, 1499, 1255, 1099, 835, 774, 692 cm–1. 
MS (EI) m/z (M+) calcd for C23H43NOSi: 377, found: 377. 
[α]24D = –7.9° (c 0.011, CH2Cl2; from (1S,2S)-1). 
 
 
Me
OO
N
n-Bu
Me
MeO
 
(S)-N-(2-Butyl-6-(2-methyl-1,3-dioxolan-2-yl)hexyl)-3-methoxy-N-methylaniline (Table 1, 
entry 8).  N-(2-Chlorohexyl)-3-methoxy-N-methylaniline (180 mg, 0.75 mmol) and a solution of 
the reagent prepared by hydroboration of 2-(but-3-enyl)-2-methyl-1,3-dioxolane with 9-BBN 
dimer (1.5 M solution in i-Pr2O; 0.90 mL, 1.35 mmol) were used.  The product was purified by 
flash chromatography on reverse-phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow 
oil.  First run: 229 mg (85%, 94% ee).  Second run: 238 mg (88%, 93% ee). 
The ee was determined by SFC on an OD-H column (5% MeOH/CO2(l)→20% 
MeOH/CO2(l), 3.0 mL/min, 100 bar) with tr = 7.2 min (minor), 8.8 min (major). 
1H NMR (400 MHz, CDCl3) δ 7.10 (t, 1H, J = 8.2 Hz), 6.29–6.26 (m, 1H), 6.23–6.18 (m, 2H), 
3.91–3.89 (m, 4H), 3.77 (s, 3H), 3.12 (d, 2H, J = 7.6 Hz), 2.90 (s, 3H), 1.80 (br s, 1H), 1.62–1.59 (m, 
2H), 1.28–1.25 (m, 15H), 0.86 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ 160.7, 151.1, 129.6, 110.1, 105.1, 100.4, 98.3, 64.6, 57.6, 55.0, 39.6, 
39.2, 36.6, 31.6, 31.3, 28.7, 26.8, 24.6, 23.7, 23.2, 14.1. 
FT-IR (neat) 2930, 1611, 1502, 1378, 1244, 1169, 1057, 948, 828, 750, 688 cm–1. 
MS (EI) m/z (M+) calcd for C22H37NO3: 363, found: 363. 
[α]23D = –4.6° (c 0.011, CH2Cl2; from (1S,2S)-1). 
 
 
                                                
(3) The silyl ether was treated with TBAF in THF (1 M; 5 equiv) and stirred for 2 h at room 
temperature. 
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n-Bu
Me
F
MeO  
(S)-3-Fluoro-N-(2-(3-(2-methoxyphenyl)propyl)hexyl)-N-methylaniline (Table 1, entry 9).  
N-(2-Chlorohexyl)-3-fluoro-N-methylaniline (180 mg, 0.74 mmol) and a solution of the reagent 
prepared by hydroboration of 2-allylanisole with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 
mL, 1.35 mmol) were used.  The product was purified by flash chromatography on reverse-
phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  First run: 183 mg (69%, 92% 
ee).  Second run: 187 mg (71%, 92% ee). 
The ee was determined by SFC on an OJ column (gradient 5%→20% MeOH/CO2(l), 3.0 
mL/min, 100 bar) with tr = 5.9 min (minor), 6.9 min (major). 
1H NMR (400 MHz, CDCl3) δ 7.24–7.14 (m, 3H), 6.93 (t, 1H, J = 7.4 Hz), 6.88 (d, 1H, J = 8.0 
Hz), 6.46–6.37 (m, 3H), 3.84 (s, 3H), 3.20 (d, 2H, J = 7.2 Hz), 2.94 (s, 3H), 2.64 (t, 2H, J = 7.8 Hz), 
1.90 (br s, 1H), 1.72–1.59 (m, 3H), 1.47–1.33 (m, 7H), 0.94 (t, 3H, J = 6.4 Hz). 
13C NMR (100 MHz, CDCl3) δ 164.1 (d, J = 240 Hz), 157.4, 151.3 (d, J = 11 Hz), 130.8, 129.9 (d, J 
= 10 Hz), 129.7 (d, J = 11 Hz), 126.9, 120.3, 110.1, 107.3 (d, J = 2 Hz), 101.8 (d, J = 21 Hz), 98.5 (d, J 
= 25 Hz), 57.3, 55.1 (d, J = 4 Hz), 39.4, 36.2, 31.4, 31.2, 30.7, 28.6, 26.6, 23.1, 14.1. 
FT-IR (neat) 2929, 1620, 1579, 1504, 1465, 1360, 1290, 1243, 1158, 1128, 1051, 1032, 1010, 910, 
821, 752, 683, 649 cm–1. 
MS (EI) m/z (M+) calcd for C23H32FNO: 357, found: 357. 
[α]24D = +6.3° (c 0.010, CH2Cl2). 
 
 
N
MeF
Cy
MeO  
(R)-N-(2-(Cyclohexylmethyl)-5-(2-methoxyphenyl)pentyl)-2-fluoro-N-methylaniline  
(Table 1, entry 10).  N-(2-Chloro-3-cyclohexylpropyl)-2-fluoro-N-methylaniline (215 mg, 0.75 
mmol) and a solution of the reagent prepared by hydroboration of 2-allylanisole with 9-BBN 
dimer (1.5 M solution in i-Pr2O; 0.90 mL, 1.35 mmol) were used.  The product was purified by 
flash chromatography on reverse-phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow 
oil.  First run: 242 mg (80%, 72% ee).  Second run: 252 mg (84%, 70% ee). 
The ee was determined by SFC on an OJ column (gradient 5%→20% MeOH/CO2(l), 3.0 
mL/min, 100 bar) with tr = 6.8 min (minor), 7.4 min (major). 
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1H NMR (400 MHz, CDCl3) δ 7.23–7.13 (m, 2H), 7.05–6.97 (m, 2H), 6.94–6.89 (m, 2H), 6.87–
6.80 (m, 2H), 3.82 (s, 3H), 3.05–2.95 (m, 2H), 2.83 (s, 3H), 2.59 (t, 2H, J = 7.6 Hz), 1.90–1.84 (m, 
1H), 1.69–1.50 (m, 7H), 1.44–1.10 (m, 8H), 0.92–0.77 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ 157.4, 155.2 (d, J = 243 Hz), 140.7 (d, J = 8 Hz), 131.1, 129.7, 
126.8, 124.1 (d, J = 3 Hz), 120.4 (d, J = 8 Hz), 120.3 (d, J = 7 Hz), 119.2 (d, J = 4 Hz), 116.1 (d, J = 21 
Hz), 110.1, 59.6 (d, J = 4 Hz), 55.1, 40.4 (d, J = 2 Hz), 40.2, 34.9, 34.1, 33.5, 32.7, 32.2, 30.6, 26.7, 
26.4. 
FT-IR (neat) 2922, 1612, 1503, 1450, 1290, 1242, 1116, 1033, 909, 823, 749, 649 cm–1. 
MS (EI) m/z (M+) calcd for C26H36FNO: 397, found: 397. 
[α]24D = +5.8° (c 0.0115, CH2Cl2). 
 
 
N
Me
Me
OMe  
(S)-N-(5-(4-Methoxyphenyl)-2-methylpentyl)-N-methylnaphthalen-2-amine (Table 1, entry 
11).  N-(2-Chloropropyl)-N-methylnaphthalen-2-amine (176 mg, 0.75 mmol) and a solution of 
the reagent prepared by hydroboration of 4-allylanisole with 9-BBN dimer (1.5 M solution in i-
Pr2O; 0.90 mL, 1.35 mmol) were used.  The product was purified by flash chromatography on 
reverse-phase silica gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  First run: 180 mg 
(69%, 83% ee).  Second run: 185 mg (71%, 83% ee). 
The ee was determined by HPLC on an OD-H column (1% isopropanol/hexanes, 1.0 
mL/min) with tr = 17.1 min (major), 18.6 min (minor). 
1H NMR (400 MHz, CDCl3) δ 7.67–7.58 (m, 3H), 7.36–7.29 (m, 1H), 7.18–7.02 (m, 4H), 6.84–
6.76 (m, 3H), 3.76 (s, 3H), 3.29 (dd, 1H, J = 6.8, 14.6 Hz), 3.14 (dd, 1H, J = 8.0, 14.6 Hz), 3.01 (s, 
3H), 2.56–2.46 (m, 2H), 2.03–1.91 (m, 1H), 1.90–1.34 (m, 3H), 1.21–1.10 (m, 1H), 0.90 (d, 3H, J = 
6.4 Hz). 
13C NMR (100 MHz, CDCl3) δ 157.8, 147.8, 135.4, 134.8, 129.4, 128.8, 127.6, 126.5, 126.3, 126.2, 
121.8, 116.1, 113.9, 113.7, 105.5, 59.9, 55.4, 39.8, 35.4, 34.4, 32.4, 31.1, 29.4, 17.9. 
FT-IR (neat) 2929, 2857, 1628, 1600, 1512, 1245, 1177, 1036, 823, 744 cm–1. 
MS (EI) m/z (M+) calcd for C24H29NO: 347.2, found: 347.2. 
[α]23D = +11.9° (c 0.0072, CHCl3). 
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(S)-1-(2-(3-(4-Fluorophenyl)propyl)hexyl)indoline (Table 1, entry 12).  1-(2-
Chlorohexyl)indoline (180 mg, 0.75 mmol) and a solution of the reagent prepared by 
hydroboration of 1-allyl-4-fluorobenzene with 9-BBN dimer (1.5 M solution in i-Pr2O; 0.90 mL, 
1.35 mmol) were used.  The product was purified by flash chromatography on reverse-phase 
silica gel (10% acetonitrile/water→acetonitrile).  Yellow oil.  First run: 154 mg (55%, 90% ee).  
Second run: 152 mg (59%, 93% ee). 
The ee was determined by SFC on an OJ column (gradient 5%→20% MeOH/CO2(l), 3.0 
mL/min, 100 bar) with tr = 7.3 min (major), 7.8 min (minor). 
1H NMR (400 MHz, CDCl3) δ 7.15–7.09 (m, 2H), 7.08–7.02 (m, 2H), 6.99–6.92 (m, 2H), 6.62 (t, 
1H, J = 7.3 Hz), 6.41 (d, 1H, J = 7.7 Hz), 3.36–3.25 (m, 2H), 2.95 (t, 2H, J = 8.4 Hz), 2.88 (d, 2H, J = 
7.2 Hz), 2.58 (t, 2H, J = 7.7 Hz), 1.76–1.57 (m, 3H), 1.49–1.23 (m, 8H), 0.90 (t, 3H, J = 6.8 Hz). 
13C NMR (100 MHz, CDCl3) δ 161.4 (d, J = 243.0 Hz), 153.6, 138.4 (d, J = 3.2 Hz), 129.9 (d, J = 
7.6 Hz), 129.8, 127.5, 124.5, 117.2, 115.1 (d, J = 21.0 Hz), 106.5, 54.7, 54.4, 37.1, 35.7, 31.8, 31.7, 29.1, 
28.9, 28.8, 23.4, 14.3. 
FT-IR (neat) 2928, 2857, 1607, 1510, 1489, 1460, 1221, 1156, 832, 743, 714 cm–1. 
MS (APCI + ESI) m/z (M+) calcd for C23H30FN: 339.2, found: 339.1. 
[α]23D = +0.97° (c 0.0071, CHCl3). 
 
 
IV.  Assignment of Absolute Stereochemistry 
 
These procedures have not been optimized. 
N
Me
n-HexMe
MeO
88% ee, from (1R,1R)-1
H2N
Me
n-Hex
[!]21D = –9.0°
[!]21D = –8.4°; >95% ee (lit.)  
(S)-2-Methyloctan-1-amine (derived from the product of Table 1, entry 5).  Anhydrous 
calcium oxide (476 mg, 8.5 mmol) was added to a solution of 4-methoxy-N-methyl-N-(2-
methyloctyl)aniline (150 mg, 0.57 mmol) in a mixture of THF (anhydrous; 3.2 mL) and MeOH 
(anhydrous; 2.4 mL) in a 20-mL vial.  The mixture was cooled to 0 °C, and a solution of iodine 
(635 mg, 2.5 mmol) in THF (1 mL) was added.  The reaction mixture was stirred at 0 °C for 3.5 h.  
Next, it was diluted with CH2Cl2 (20 mL), and the reaction was quenched by the addition of 
aqueous sodium thiosulfate (15%; 50 mL).  The organic layer was separated and then washed 
 S–16 
with water (20 mL) and brine (10 mL), dried over Na2SO4, and concentrated by rotary 
evaporation to give a dark-brown oil.  The oil was dissolved in a mixture of acetonitrile (0.8 mL) 
and water (0.8 mL), and then trichloroisocyanuric acid (116 mg, 0.50 mmol) was added in a 
single portion, followed by aqueous HCl (2 M; 1 mL).  The reaction mixture was stirred at r.t. for 
4 h, and then the acetonitrile was removed by rotary evaporation.  The product was extracted 
into CH2Cl2, and the solution was concentrated on a rotary evaporator.  The product was 
purified by Kugelrohr distillation (oven temperature: 90 °C; 9 torr), which provided the product 
as a colorless oil (34 mg, 42%).  The absolute stereochemistry was determined to be (S) by 
comparison with a reported optical rotation.4 
 
 
84% ee, from (1R,1R)-1
[!]21D = –7.4°
[!]21D = –10.6°; >95% ee (lit.)
N
Me
Me
MeO
Me
Me
H2N
Me
Me
Me
 
(S)-2,6-Dimethylheptan-1-amine (derived from the product of Table 1, entry 6).  The same 
conditions employed for the synthesis of (S)-2-methyloctan-1-amine were used, except with N-
(2,6-dimethylheptyl)-4-methoxy-N-methylaniline (150 mg, 0.57 mmol) as the starting material.  
Yield (unoptimized): 31 mg, 38%.  The absolute stereochemistry of the cross-coupling product 
obtained with ligand (1R,1R)-1 was determined to be (S) by comparison with a reported optical 
rotation.4 
 
                                                
(4) Enders, D.; Schubert, H. Angew. Chem Int. Ed. Engl. 1984, 23, 365–366. 
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